State Street Corp. Discloses Passive Stake in Vir Biotechnology

TL;DR

**State Street just revealed a passive stake in Vir Biotechnology, signaling institutional interest.**

AI Summary

State Street Corporation, a major financial institution, reported an initial filing on January 24, 2024, disclosing its ownership of Vir Biotechnology, Inc. common stock as of December 31, 2023. This filing, an SC 13G, indicates that State Street holds a passive investment in Vir Biotechnology, meaning they are not seeking to influence management. For investors, this signals that a large institutional player sees value in Vir Biotechnology, potentially adding a layer of stability or validation to the stock.

Why It Matters

This filing shows a significant institutional investor, State Street Corporation, has taken a passive stake in Vir Biotechnology, which can be a positive signal for other investors.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of a passive investment by a large institution, posing minimal direct risk to investors.

Analyst Insight

Investors should note the presence of a major institutional holder like State Street, which can provide some stability, but also understand this is a passive stake, not an activist one. Further research into Vir Biotechnology's fundamentals is warranted.

Key Numbers

• 92764N102 — CUSIP Number (identifies Vir Biotechnology, Inc. common stock)
• 12/31/2023 — Date of Event (the date as of which the ownership was determined)
• 04-2456637 — IRS Identification No. (identifies State Street Corporation)

Key Players & Entities

• State Street Corporation (company) — the reporting person and institutional investor
• Vir Biotechnology, Inc. (company) — the subject company whose common stock is being reported
• 0000093751-24-000114 (dollar_amount) — accession number for the filing

Forward-Looking Statements

• Other institutional investors may view State Street's passive stake as a positive signal, potentially leading to increased institutional interest in Vir Biotechnology. (Vir Biotechnology, Inc.) — medium confidence, target: Q2 2024

FAQ

From the Filing

0000093751-24-000114.txt : 20240124 0000093751-24-000114.hdr.sgml : 20240124 20240124075912 ACCESSION NUMBER: 0000093751-24-000114 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91177 FILM NUMBER: 24554269 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STATE STREET CORP CENTRAL INDEX KEY: 0000093751 STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022] ORGANIZATION NAME: 02 Finance IRS NUMBER: 042456637 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1 CONGRESS STREET STREET 2: SUITE 1 CITY: BOSTON STATE: MA ZIP: 02114 BUSINESS PHONE: 617 786-3000 MAIL ADDRESS: STREET 1: 1 CONGRESS STREET STREET 2: SUITE 1 CITY: BOSTON STATE: MA ZIP: 02114 FORMER COMPANY: FORMER CONFORMED NAME: STATE STREET Corp DATE OF NAME CHANGE: 20090218 FORMER COMPANY: FORMER CONFORMED NAME: STATE STREET CORP DATE OF NAME CHANGE: 19970424 FORMER COMPANY: FORMER CONFORMED NAME: STATE STREET BOSTON FINANCIAL CORP DATE OF NAME CHANGE: 19780525 SC 13G 1 Vir_Biotech_Inc.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 INITIAL FILING VIR BIOTECHNOLOGY INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 92764N102 (CUSIP NUMBER) 12/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: (X) RULE 13D-1 (B) ( ) RULE 13D-1 (C) ( ) RULE 13D-1 (D) *THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING PERSON`S INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF SECURITIES, AND FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH WOULD ALTER THE DISCLOSURES PROVIDED IN A PRIOR COVER PAGE. THE INFORMATION REQUIRED IN THE REMAINDER OF THIS COVER PAGE SHALL NOT BE DEEMED TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT SECTION OF THE ACT BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT (HOWEVER, SEE THE NOTES). CUSIP NO:92764N102 13G Page 2 of 5 Pages 1. NAME OF REPORTING PERSON: STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON: 04-2456637 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP NOT APPLICABLE 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION BOSTON, MASSACHUSETTS 5. SOLE VOTING POWER 0 SHARES 6. SHARED VOTING POWER 6,693,184 7. SOLE DISPOSITIVE POWER 0 SHARES 8. SHARED DISPOSITIVE POWER 6,912,082 9. AGGREGATED AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,912,082 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES NOT APPLICABLE 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.14% 12. TYPE OF REPORTING PERSON HC CUSIP NO: 92764N102 13G Page 3 of 5 Pages ITEM 1. (A) NAME OF ISSUER VIR BIOTECHNOLOGY INC (B) ADDRESS OF ISSUER`S PRINCIPAL EXECUTIVE OFFICES 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 UNITED STATES ITEM 2. (A) NAME OF PERSON FILING STATE STREET CORPORATION (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE STATE STREET FINANCIAL CENTER 1 CONGRESS STREET, SUITE 1 BOSTON, MA 02114-2016 (FOR ALL REPORTING PERSONS) (C) CITIZENSHIP: SEE ITEM 4 (CITIZENSHIP OR PLACE OF ORGANIZATION) OF COVER PAGES (D) TITLE OF C